MeiraGTx Holdings (MGTX)

• Market cap: $730M
• 1 day: 4.01%
• 5 days: 3.89%
• 1 month: 10.33%
• 3 months: 18.69%
• 6 months: 28.07%
• Year to date: 44.82%
• 1 year: 63.9%
• 5 years: -31.68%
• 10 years: -39.47%
• Sector: Healthcare
• Industry: Biotechnology

About: MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Employees: 386